Generate Biomedicines, Inc. (GENB)
14.34
+0.36
(+2.54%)
USD |
NASDAQ |
Oct 09, 16:00
14.34
0.00 (0.00%)
After-Hours: 20:00
Generate Biomedicines Net Income (Quarterly) : -67.26M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -67.26M |
| March 31, 2026 | -61.71M |
| Date | Value |
|---|---|
| June 30, 2025 | -56.74M |
| March 31, 2025 | -44.31M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Twist Bioscience Corp. | -35.05M |
| Intellia Therapeutics, Inc. | -106.63M |
| Prime Medicine, Inc. | -42.11M |
| Moderna, Inc. | -782.00M |
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 6.314M |
| Total Expenses (Quarterly) | 73.57M |
| EPS Diluted (Quarterly) | -0.5243 |
| Enterprise Value | 1.400B |
| Gross Profit Margin (Quarterly) | 48.94% |
| Profit Margin (Quarterly) | -1.07K% |
| Earnings Yield | -32.20% |
| Normalized Earnings Yield | -32.18 |